Judson, I., Morden, J. P., Kilburn, L., Leahy, M., Benson, C., Bhadri, V., . . . Bliss, J. M. (2019). Cediranib in patients with alveolar soft-part sarcoma (CASPS): A double-blind, placebo-controlled, randomised, phase 2 trial. Lancet Oncol.
Citação norma ChicagoJudson, Ian, et al. "Cediranib in Patients With Alveolar Soft-part Sarcoma (CASPS): A Double-blind, Placebo-controlled, Randomised, Phase 2 Trial." Lancet Oncol 2019.
MLA CitationJudson, Ian, et al. "Cediranib in Patients With Alveolar Soft-part Sarcoma (CASPS): A Double-blind, Placebo-controlled, Randomised, Phase 2 Trial." Lancet Oncol 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.